Hangzhou Wensli Silk Culture
301066
Yoantion Industrial Inc.,
301053
Xinlei Compressor
301317
4
QIFENG
873169
5
LAISAI LASER
871263
CN Stock MarketDetailed Quotes
600721 Xinjiang Bai Hua Cun Pharma Tech
- 7.09
- -0.12-1.66%
Market Closed May 9 15:00 CST
2.72BMarket Cap65.65P/E (TTM)
7.27High7.06Low213.96KlotVolume7.21Open7.21Pre Close152.84MTurnover5.57%Turnover Ratio65.65P/E (Static)384.14MShares8.6752wk High3.49P/B2.72BFloat Cap5.0752wk Low7.93Limit Up384.14MShs Float26.18Historical High6.49Limit Down2.91%Amplitude1.96Historical Low--Dividend TTM7.14Avg Price113.52KlotAsk--Div YieldTTM100Lot Size88.82KlotBid
Xinjiang Bai Hua Cun Pharma Tech Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 6.65%96.92M | 4.46%385.76M | 9.38%290.63M | 17.40%196.3M | 20.03%90.88M | 5.54%369.28M | 3.65%265.71M | 2.11%167.21M | 28.77%75.71M | 24.36%349.88M |
| Operating revenue | 6.65%96.92M | 4.46%385.76M | 9.38%290.63M | 17.40%196.3M | 20.03%90.88M | 5.54%369.28M | 3.65%265.71M | 2.11%167.21M | 28.77%75.71M | 24.36%349.88M |
| Other operating revenue | ---- | -25.52%2.28M | ---- | -25.82%1.89M | ---- | -12.76%3.06M | ---- | -22.49%2.55M | ---- | 8.86%3.51M |
| Total operating cost | 2.06%69.79M | -2.70%293.05M | 7.19%236.01M | 10.55%157.35M | 5.02%68.38M | -6.89%301.19M | -3.49%220.18M | -0.34%142.33M | 20.16%65.12M | 30.58%323.49M |
| Operating cost | 8.53%47.09M | 0.05%188.3M | 13.07%155.59M | 15.24%102.56M | 12.26%43.39M | -10.48%188.19M | -8.20%137.6M | -7.00%89M | 22.01%38.65M | 24.61%210.22M |
| Operating tax surcharges | -4.54%1.15M | -0.60%5.22M | 8.06%3.72M | 17.26%2.61M | 29.82%1.2M | 9.46%5.25M | 2.67%3.44M | -11.54%2.22M | -22.15%927.58K | 3.13%4.79M |
| Operating expense | 5.37%2.43M | -13.52%11.37M | 10.15%9.21M | 25.32%6.89M | -11.89%2.31M | -14.79%13.15M | -7.87%8.36M | 3.34%5.5M | -0.77%2.62M | 96.12%15.43M |
| Administration expense | -16.25%13.24M | -5.62%60.03M | -7.90%46.19M | -4.35%31.98M | -6.26%15.8M | -3.41%63.6M | 3.16%50.15M | 16.01%33.44M | 17.72%16.86M | 7.27%65.85M |
| Financial expense | 7.54%-299.92K | -61.64%-1.4M | -66.52%-970.46K | -50.11%-637.4K | -293.16%-324.38K | -214.01%-866.17K | -590.69%-582.79K | -1,512.71%-424.62K | -1,329.71%-82.51K | -158.35%-275.84K |
| -Interest expense (Financial expense) | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | 138.43%112.58K |
| -Interest Income (Financial expense) | 11.93%-317.96K | -43.43%-1.47M | -37.43%-1.04M | -34.78%-692.47K | -185.62%-361.03K | -95.78%-1.02M | -171.73%-758.73K | -192.56%-513.77K | -64.36%-126.4K | -135.80%-521.76K |
| Research and development | 3.04%6.18M | -7.28%29.55M | 5.03%22.27M | 10.73%13.95M | -2.26%6M | 15.96%31.87M | 22.69%21.2M | 20.18%12.6M | 41.02%6.14M | 423.36%27.48M |
| Credit Impairment Loss | -357.32%-4.04M | -296.77%-17.05M | -67.33%-4.31M | -82.43%-3.38M | -226.00%-883.66K | -108.87%-4.3M | -174.55%-2.57M | -135.70%-1.85M | 48.65%-271.06K | -42.89%-2.06M |
| Asset Impairment Loss | -2,287.43%-2.14M | 11.91%-43.46M | -3.81%-26.42M | -35.95%-12.99M | 97.58%-89.83K | 14.07%-49.33M | -101.89%-25.45M | -44.71%-9.56M | -109.73%-3.71M | -208.16%-57.41M |
| Other net revenue | -908.01%-5.19M | -11.05%-55.67M | -10.96%-27.48M | -43.18%-14.07M | 83.77%-514.5K | 12.25%-50.13M | -73.70%-24.76M | -12.67%-9.83M | -22.24%-3.17M | -290.86%-57.13M |
| Fair value change income | ---- | -117.73%-125K | ---- | ---- | ---- | -9.27%704.94K | ---- | ---- | ---- | -69.25%776.96K |
| Invest income | 147.39%630.16K | 179.65%3.5M | 8.07%2.56M | 84.10%1.74M | -47.56%254.72K | 263.16%1.25M | 203.76%2.37M | 145.11%947.6K | 170.93%485.72K | 63.30%-766K |
| -Including: Investment income associates | 2,313.92%296.6K | 431.47%1.05M | -43.08%813.12K | 43.24%602.06K | -104.56%-13.4K | 78.86%-315.5K | 152.15%1.43M | 117.86%420.32K | 138.27%293.69K | 36.58%-1.49M |
| Asset deal income | ---- | 526.59%89.53K | 1,685.33%86.26K | 1,685.33%86.26K | 363.46%22.39K | 1,144.34%14.29K | --4.83K | --4.83K | --4.83K | -76.23%1.15K |
| Other revenue | 103.13%369.45K | -9.91%1.38M | -31.77%608.19K | -25.60%465.99K | -43.29%181.87K | -34.08%1.53M | -43.32%891.38K | -18.16%626.34K | -17.42%320.74K | -95.32%2.32M |
| Operating profit | -0.18%21.94M | 106.26%37.04M | 30.66%27.14M | 65.25%24.88M | 196.02%21.98M | 158.41%17.96M | 48.80%20.77M | 23.16%15.05M | 269.17%7.43M | -148.38%-30.74M |
| Add:Non operating Income | -96.08%3.86K | 40.59%175.46K | 76.57%113.1K | 128.33%98.58K | 228.88%98.58K | 17.14%124.8K | -75.06%64.05K | -81.86%43.17K | 2,631.86%29.97K | -48.59%106.54K |
| Less:Non operating expense | -11.57%52.71K | -78.33%346.61K | -58.70%202.5K | -57.52%177.27K | -0.51%59.6K | 7.93%1.6M | -59.42%490.34K | -48.22%417.32K | 734.52%59.91K | -5.83%1.48M |
| Total profit | -0.58%21.89M | 123.67%36.86M | 32.96%27.05M | 68.93%24.8M | 197.75%22.02M | 151.32%16.48M | 56.40%20.35M | 25.95%14.68M | 268.80%7.4M | -151.65%-32.12M |
| Less:Income tax cost | -13.68%1.17M | -231.50%-4.61M | 16.74%3.1M | 27.22%2.14M | 91.40%1.36M | 33.85%3.51M | 31.86%2.65M | 25.21%1.68M | 13.13%708.61K | 13.93%2.62M |
| Net profit | 0.28%20.72M | 219.75%41.48M | 35.39%23.95M | 74.32%22.66M | 209.02%20.66M | 137.34%12.97M | 60.90%17.69M | 26.04%13M | 384.94%6.69M | -158.02%-34.74M |
| Net profit from continuing operation | 0.28%20.72M | 219.75%41.48M | 35.39%23.95M | 74.32%22.66M | 209.02%20.66M | 137.34%12.97M | 60.90%17.69M | 26.04%13M | 384.94%6.69M | -158.02%-34.74M |
| Less:Minority Profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -41.74%27.46K |
| Net profit of parent company owners | 0.28%20.72M | 219.75%41.48M | 35.39%23.95M | 74.32%22.66M | 209.02%20.66M | 137.31%12.97M | 60.90%17.69M | 26.28%13M | 387.32%6.69M | -158.11%-34.76M |
| Earning per share | ||||||||||
| Basic earning per share | -0.18%0.054 | 217.25%0.1085 | 33.97%0.0627 | 72.67%0.0594 | 205.65%0.0541 | 136.97%0.0342 | 59.73%0.0468 | 25.55%0.0344 | 378.38%0.0177 | -157.99%-0.0925 |
| Diluted earning per share | -0.19%0.0539 | 217.25%0.1085 | 34.05%0.0626 | 72.59%0.0592 | 206.82%0.054 | 137.21%0.0342 | 59.93%0.0467 | 26.57%0.0343 | 388.89%0.0176 | -157.62%-0.0919 |
| Other composite income | 29.54%-98.65K | 38.81%-140K | -20.35%-228.79K | |||||||
| Other composite income of parent company owners | ---- | 29.54%-98.65K | ---- | ---- | ---- | 38.81%-140K | ---- | ---- | ---- | -20.35%-228.79K |
| Total composite income | 0.28%20.72M | 222.47%41.38M | 35.39%23.95M | 74.32%22.66M | 209.02%20.66M | 136.70%12.83M | 60.90%17.69M | 26.04%13M | 384.94%6.69M | -158.59%-34.97M |
| Total composite income of parent company owners | 0.28%20.72M | 222.47%41.38M | 35.39%23.95M | 74.32%22.66M | 209.02%20.66M | 136.67%12.83M | 60.90%17.69M | 26.28%13M | 387.32%6.69M | -158.68%-34.99M |
| Total composite income of minority owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -41.74%27.46K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Sigma Certified Public Accountants (Special General Partnership) | -- | -- | -- | Sigma Certified Public Accountants (Special General Partnership) | -- | -- | -- | Sigma Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.